Columbia University Medical Center’s Andrew Kung, MD, PhD Leads Spring Evening Talks at New York Genome Center
The New York Genome Center (NYGC) continues its Evening Talks this March, with esteemed speaker, Andrew Kung, MD, PhD (Chief of the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation at NewYork-Presbyterian/Morgan Stanley Children’s Hospital and Columbia University Medical Center).
On March 22, Dr. Kung joins us to explain the clinical impact of precision medicine for children with cancer. Through his work as Chief of the Division of Pediatric Hematology, Oncology and Stem Cell Transplantation at Columbia, Dr. Kung’s goal is providing exceptional care for todays young patients while developing therapies for the next generation of children.
Dr. Kung’s research program focuses on identifying new ways to treat childhood cancer by applying a cross-disciplinary approach to identifying vulnerabilities in different kinds of cancer, and developing novel treatments that “exploit” these weaknesses. The research in Dr. Kung’s lab has led to clinical trials of promising new therapies for patients with brain tumors, blood cancers and sarcomas.
Dr. Kung will speak on Tuesday, March 22 at 6:00 pm at NYGC, located in Soho at 101 Avenue of the Americas between Grand and Watts Streets. The talk will be followed by cocktails and hors d’oeuvres, and a chance to meet the speaker.
About Evening Talks
Evening Talks are NYGC’s monthly lecture, bringing world-class speakers to explore new genomic insights into health, history and more with New Yorkers of all backgrounds. Unlike Five Points Lectures, which are geared towards a more scientific audience, Evening Talks address listeners of more varied expertise, including layfolk.
About the New York Genome Center
The New York Genome Center (NYGC) is an independent, nonprofit at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations and partners are united in this unprecedented collaboration of technology, science, and medicine. We harness the power of innovation and discoveries to improve people’s lives — ethically, equitably, and urgently. Member institutions include: Albert Einstein College of Medicine, American Museum of Natural History, Cold Spring Harbor Laboratory, Columbia University, Cornell University/Weill Cornell Medicine, Hospital for Special Surgery, The Jackson Laboratory, Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, NewYork-Presbyterian Hospital, The New York Stem Cell Foundation, New York University, Northwell Health (formerly North Shore-LIJ), The Rockefeller University, Roswell Park Cancer Institute, Stony Brook University and IBM.
Eva Chodosh, Senior Communications Associate
646.977.7413 / email@example.com